ATE359817T1 - Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffe - Google Patents

Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffe

Info

Publication number: ATE359817T1
Authority: AT; Austria
Prior art keywords: vaccines; based adjuvant; formyl methionyl; methionyl peptide; formyl
Prior art date: 1998-12-18

Application number

AT99969285T

Other languages

English (en)

Inventor

Jeannine Alexander

William I Cox

Original Assignee

Connaught Technology Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-18

Filing date

1999-12-17

Publication date

2007-05-15

1999-12-17 Application filed by Connaught Technology Corp filed Critical Connaught Technology Corp

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE359817T1 publication Critical patent/ATE359817T1/de

Links

-1 N-FORMYL METHIONYL Chemical class 0.000 title abstract 2
239000002671 adjuvant Substances 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 title 1
PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 abstract 2
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
239000000568 immunological adjuvant Substances 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y10S977/917—Vaccine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/918—Immunological
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/92—Detection of biochemical

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

AT99969285T 1998-12-18 1999-12-17 Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffe ATE359817T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/216,702 US6017537A (en)	1998-12-18	1998-12-18	Formyl methionyl peptide vaccine adjuvant

Publications (1)

Publication Number	Publication Date
ATE359817T1 true ATE359817T1 (de)	2007-05-15

Family

ID=22808169

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT99969285T ATE359817T1 (de)	1998-12-18	1999-12-17	Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffe
AT07007842T ATE496630T1 (de)	1998-12-18	1999-12-17	Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT07007842T ATE496630T1 (de)	1998-12-18	1999-12-17	Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten

Country Status (14)

Country	Link
US (1)	US6017537A (de)
EP (2)	EP1800692B1 (de)
JP (1)	JP2002532436A (de)
AT (2)	ATE359817T1 (de)
AU (1)	AU773697B2 (de)
CA (2)	CA2718376A1 (de)
CY (2)	CY1106635T1 (de)
DE (2)	DE69943170D1 (de)
DK (2)	DK1140166T3 (de)
ES (2)	ES2284285T3 (de)
NZ (1)	NZ510544A (de)
PT (2)	PT1800692E (de)
SI (2)	SI1140166T1 (de)
WO (1)	WO2000035482A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010018579A1 (en)	1998-12-18	2001-08-30	Walter Klemp	Disposable absorbent garment having stretchable side waist regions
GB9924351D0 (en)	1999-10-14	1999-12-15	Brennan Frank	Immunomodulation methods and compositions
US20030050249A1 (en) *	2000-05-23	2003-03-13	Clagett James A.	Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
US20070025958A1 (en) *	2000-10-27	2007-02-01	Hadden John W	Vaccine immunotherapy
AU2002232560A1 (en) *	2000-10-27	2002-05-06	Immuno-Rx, Inc	Vaccine immunotherapy for immune suppressed patients
EP1545575A4 (de)	2002-09-19	2006-04-05	Us Gov Health & Human Serv	P. ariasi polypeptide, p. perniciosus polypeptide und anwendungsverfahren
ES2447843T3 (es)	2002-10-29	2014-03-13	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Polip�ptidos de Lutzomyia longipalpis y m�todos de uso
EP1581558A2 (de) *	2003-01-07	2005-10-05	Neuromed Technologies, Inc.	Fluoreszenz-basiertes t-typ ionenkanal-testverfahren
US7425700B2 (en) *	2003-05-22	2008-09-16	Stults John T	Systems and methods for discovery and analysis of markers
US9592277B2 (en) *	2004-04-14	2017-03-14	Avirid, Inc.	Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
US7998733B2 (en)	2004-10-05	2011-08-16	Merial Limited	Chimeric vectors
AU2006210392A1 (en) *	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune response modifiers
US7887522B2 (en) *	2005-03-18	2011-02-15	The Procter And Gamble Company	Pull-on wearable article with informational image
US7806880B2 (en) *	2005-03-18	2010-10-05	The Procter & Gamble Company	Pull-on wearable article with informational image
US20060264858A1 (en) *	2005-05-20	2006-11-23	Roe Donald C	Multi-functional training garment
US20070178115A1 (en)	2005-08-15	2007-08-02	Tang De-Chu C	Immunization of avians by administration of non-replicating vectored vaccines
US7432413B2 (en)	2005-12-16	2008-10-07	The Procter And Gamble Company	Disposable absorbent article having side panels with structurally, functionally and visually different regions
US8664467B2 (en)	2006-03-31	2014-03-04	The Procter & Gamble Company	Absorbent articles with feedback signal upon urination
CN101528263B (zh) *	2006-06-30	2013-01-23	Sku资产管理有限公司	用于癌症的先天性免疫方法的缀合物
CA2671929C (en) *	2006-12-04	2013-03-19	The Procter & Gamble Company	Absorbent articles comprising graphics
MX2010012069A (es)	2008-05-08	2010-12-14	Merial Ltd	Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena.
US9400873B2 (en)	2011-12-21	2016-07-26	Deka Products Limited Partnership	System, method, and apparatus for dispensing oral medications
AU2011230619C1 (en)	2010-03-25	2016-06-23	Oregon Health & Science University	CMV glycoproteins and recombinant vectors
HUE037408T2 (hu)	2011-06-10	2018-08-28	Univ Oregon Health & Science	CMV glikoproteinek és rekombináns vektorok
US8895027B2 (en)	2011-07-20	2014-11-25	Merial Limited	Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
MX350096B (es)	2011-08-12	2017-08-25	Merial Inc	Preservación asistida con vacío de productos biológicos, en particular de vacunas.
CA2789539A1 (en)	2011-09-12	2013-03-12	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
US10563681B2 (en)	2011-12-21	2020-02-18	Deka Products Limited Partnership	System, method, and apparatus for clamping
US12205697B2 (en)	2011-12-21	2025-01-21	Deka Products Limited Partnership	Pill dispenser
ES2711878T3 (es)	2012-03-20	2019-05-08	Merial Inc	Vacuna contra el virus del herpes equino 1 recombinante que contiene glicoproteína C mutada y usos de la misma
WO2013170433A1 (en)	2012-05-15	2013-11-21	The Procter & Gamble Company	Absorbent article having characteristic waist end
ES2631608T3 (es)	2012-06-27	2017-09-01	International Aids Vaccine Initiative	Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de)	2013-09-05	2015-03-18	International Aids Vaccine Initiative	Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en)	2013-10-07	2018-08-28	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
NZ726315A (en)	2014-05-14	2018-04-27	Merial Inc	Methods for freeze-drying and rehydrating biologics
EP3069730A3 (de)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en)	2015-03-23	2018-04-03	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
KR102726776B1 (ko) *	2021-07-09	2024-11-06	포항공과대학교 산학협력단	포밀 메티오닌 특이 항체 제조를 위한 신규한 항원 펩타이드

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL89118A0 (en) *	1988-02-03	1989-08-15	Microgenesys Inc	Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
US5861158A (en) *	1993-11-17	1999-01-19	The United States Of America As Represented By The Deptartment Of Health And Human Services	Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor

1998
- 1998-12-18 US US09/216,702 patent/US6017537A/en not_active Expired - Lifetime
1999
- 1999-12-17 PT PT07007842T patent/PT1800692E/pt unknown
- 1999-12-17 CA CA2718376A patent/CA2718376A1/en not_active Abandoned
- 1999-12-17 NZ NZ510544A patent/NZ510544A/xx not_active IP Right Cessation
- 1999-12-17 DK DK99969285T patent/DK1140166T3/da active
- 1999-12-17 ES ES99969285T patent/ES2284285T3/es not_active Expired - Lifetime
- 1999-12-17 EP EP07007842A patent/EP1800692B1/de not_active Expired - Lifetime
- 1999-12-17 DK DK07007842.3T patent/DK1800692T3/da active
- 1999-12-17 SI SI9930961T patent/SI1140166T1/sl unknown
- 1999-12-17 AT AT99969285T patent/ATE359817T1/de active
- 1999-12-17 CA CA2342609A patent/CA2342609C/en not_active Expired - Fee Related
- 1999-12-17 AU AU28451/00A patent/AU773697B2/en not_active Ceased
- 1999-12-17 PT PT99969285T patent/PT1140166E/pt unknown
- 1999-12-17 EP EP99969285A patent/EP1140166B1/de not_active Expired - Lifetime
- 1999-12-17 DE DE69943170T patent/DE69943170D1/de not_active Expired - Lifetime
- 1999-12-17 SI SI9931051T patent/SI1800692T1/sl unknown
- 1999-12-17 DE DE69935866T patent/DE69935866T2/de not_active Expired - Lifetime
- 1999-12-17 ES ES07007842T patent/ES2358540T3/es not_active Expired - Lifetime
- 1999-12-17 JP JP2000587801A patent/JP2002532436A/ja active Pending
- 1999-12-17 WO PCT/US1999/030188 patent/WO2000035482A2/en not_active Ceased
- 1999-12-17 AT AT07007842T patent/ATE496630T1/de active
2007
- 2007-06-04 CY CY20071100731T patent/CY1106635T1/el unknown
2011
- 2011-04-05 CY CY20111100355T patent/CY1111372T1/el unknown

Also Published As

Publication number	Publication date
CA2718376A1 (en)	2000-06-22
DE69935866T2 (de)	2008-01-10
EP1140166A2 (de)	2001-10-10
PT1800692E (pt)	2011-03-31
US6017537A (en)	2000-01-25
WO2000035482A3 (en)	2000-10-26
HK1110769A1 (en)	2008-07-25
JP2002532436A (ja)	2002-10-02
NZ510544A (en)	2003-04-29
AU2845100A (en)	2000-07-03
CA2342609C (en)	2010-11-16
DE69935866D1 (de)	2007-05-31
EP1140166B1 (de)	2007-04-18
CY1106635T1 (el)	2012-01-25
AU773697B2 (en)	2004-06-03
DK1140166T3 (da)	2007-07-02
EP1800692A1 (de)	2007-06-27
ATE496630T1 (de)	2011-02-15
DE69943170D1 (de)	2011-03-10
WO2000035482A2 (en)	2000-06-22
CY1111372T1 (el)	2015-08-05
DK1800692T3 (da)	2011-03-28
CA2342609A1 (en)	2000-06-22
EP1800692B1 (de)	2011-01-26
ES2358540T3 (es)	2011-05-11
SI1140166T1 (sl)	2007-08-31
SI1800692T1 (sl)	2011-05-31
ES2284285T3 (es)	2007-11-01
PT1140166E (pt)	2007-06-27

Legal Events

Date

Code

Title

Description

2007-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1140166

Country of ref document: EP

Publication	Publication Date	Title
ATE359817T1 (de)	2007-05-15	Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffe
EP0667786A4 (de)	1997-08-06	Retro-, inverso-, und retro-inverso synthetische peptidanaloge.
MY103182A (en)	1993-05-29	Vaccines against acquired immune deficiency syndrome.
IS4518A (is)	1999-01-10	Nýtt lyfjaform fyrir bóluefni
BG98523A (en)	1995-05-31	Hla-limited cytotoxic t-lymphocytic (ctl) epitopes of the virus of hepatite b
EA199700272A1 (ru)	1998-04-30	Вакцины, содержащие сапонин и стерин
ATE320493T1 (de)	2006-04-15	Modifizierung des hepatitis b kernantigens
ES2075440T3 (es)	1995-10-01	Vacuna contra la hepatitis b.
ATE47524T1 (de)	1989-11-15	Hundeparvovirus-impfstoffe.
DK0895538T3 (da)	2002-11-04	Muterede ras-peptider til frembringelse af cytotoksiske CD8+-T-lymfocytter
ATE141328T1 (de)	1996-08-15	Rekombinante vakzine gegen coccidiose
DE60036692D1 (de)	2007-11-22	Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion
EA200100395A1 (ru)	2001-10-22	Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
NO924271L (no)	1993-01-07	Vaksiner med forbedret immunogenisitet
WO2004022092A3 (en)	2004-04-29	Flagellin peptides as adjuvants for vaccines
ATE154244T1 (de)	1997-06-15	Induzierung eines schutzes gegen virale infektionen
UA42741C2 (uk)	2001-11-15	Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
ATE312923T1 (de)	2005-12-15	Moraxella catarrhalis basb034 polypeptide und verwendungen davon
ATE431745T1 (de)	2009-06-15	Ltb4 als adjuvans für impfstoffe
WO2001043769A3 (en)	2001-12-27	Antigen delivery
ZA916106B (en)	1992-06-24	Cloning and expression of a rhoptry-associated protein of p.falciparum
DK43991D0 (da)	1991-03-12	Allele varianter af plasmodium falciparum merozoitoverfladeantigen
PL442478A1 (pl)	2024-04-15	Kompozycja szczepionki do zastosowania w profilaktyce chorób zakaźnych
BE905492A (fr)	1987-03-25	Vaccin contre le syndrome immunodeficitaire acquis et intermediaires antigeniques pour dosages immunologiques de depistage de ce syndrome.